Stephanie Trunk’s Perspectives

310 total results. Page 21 of 26.

Health Care Counsel Blog
The Secret's Out: FDA Allows Drug and Device Manufacturers to Share HCEI Prior to Product Approval
Health Care Counsel Blog
Life’s a Breach - Sitting on that HIPAA Breach Notification Could Burn You
Health Care Counsel Blog
New Year…Same Rules? HHS Makes Few Changes in Recent 340B Drug Pricing Program Final Rule
Health Care Counsel Blog
New Final Regulations Provide Overdue Guidance on Permissible Arrangements Between Providers, Financial Relief for Patients
Health Care Counsel Blog
US Attorney Announces Kickback and False Claims Act Settlement with Device Manufacturer BioTelmetry/MedNet
Health Care Counsel Blog
FDA Issues Final Version of Guidance for Industry, Contract Manufacturing Arrangements for Drugs: Quality Agreements
Health Care Counsel Blog
FDA Announcement on Guidance for Industry, Generic Drug User Fee Amendments of 2012
Health Care Counsel Blog
CMS Publishes Covered Outpatient Drug Final Rule
Health Care Counsel Blog
Drug Manufacturers Participating in 340B Program Must Execute New Pricing Agreement Addendum
Health Care Counsel Blog
Mylan Agrees to $465 Million Settlement with DOJ Over EpiPen Medicaid Drug Rebate Reporting Classification
Alerts
Is the Discount Safe Harbor No Longer “Safe?”
Health Care Counsel Blog
Is the Discount Safe Harbor No Longer ‘Safe?’